{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T18:55:43Z","timestamp":1696272943967},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T00:00:00Z","timestamp":1181174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10549-007-9614-8","type":"journal-article","created":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T08:44:45Z","timestamp":1181119485000},"page":"435-453","source":"Crossref","is-referenced-by-count":13,"title":["Interest in breast cancer chemoprevention among older women"],"prefix":"10.1007","volume":"108","author":[{"given":"Jennifer","family":"Tjia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellyn","family":"Micco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,7]]},"reference":[{"key":"9614_CR1","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","volume":"295","author":"VG Vogel","year":"2006","unstructured":"Vogel VG, Costantino JP, Wickerham DL et al (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 Trial. JAMA 295:2727\u20132741","journal-title":"JAMA"},{"key":"9614_CR2","first-page":"531","volume":"3","author":"V Vogel","year":"2005","unstructured":"Vogel V (2005) Chemoprevention in breast cancer. Clin Adv Hematol Oncol 3:531\u2013533","journal-title":"Clin Adv Hematol Oncol"},{"key":"9614_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-137-1-200207020-00017","volume":"137","author":"LS Kinsinger","year":"2002","unstructured":"Kinsinger LS, Harris R, Woolf SH et al (2002) Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:59\u201369","journal-title":"Ann Intern Med"},{"key":"9614_CR4","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.1999.17.6.1939","volume":"17","author":"RT Chlebowski","year":"1999","unstructured":"Chlebowski RT, Collyar DE, Somerfield MR et al (1999) American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clinl Oncol 17:1939\u20131955","journal-title":"J Clinl Oncol"},{"key":"9614_CR5","first-page":"1681","volume":"164","author":"M Levine","year":"2001","unstructured":"Levine M, Moutquin JM, Walton R et al (2001) Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative\u2019s Steering Committee on clinical practice guidelines for the care and treatment of breast cancer. CMAJ 164:1681\u20131690","journal-title":"CMAJ"},{"key":"9614_CR6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2318-6-10","volume":"6","author":"CL Lewis","year":"2006","unstructured":"Lewis CL, Kistler CE, Amick HR et al (2006) Older adults\u2019 attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatr 6:10","journal-title":"BMC Geriatr"},{"key":"9614_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2296-7-9","volume":"7","author":"CE Kistler","year":"2006","unstructured":"Kistler CE, Lewis CL, Amick HR et al (2006) Older adults\u2019 beliefs about physician-estimated life expectancy: a cross-sectional survey. BMC Fam Prac 7:9","journal-title":"BMC Fam Prac"},{"key":"9614_CR8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/archinte.165.18.2083","volume":"165","author":"JPW Bynum","year":"2005","unstructured":"Bynum JPW, Braunstein JB, Sharkey P et al (2005). The influence of health status, age, and race on screening mammography in elderly women. Arch Intern Med 165:2083\u20132088","journal-title":"Arch Intern Med"},{"key":"9614_CR9","first-page":"2167","volume":"146","author":"Z Mah","year":"1992","unstructured":"Mah Z, Bryant H (1992) Age as a factor in breast cancer knowledge, attitudes and screening behaviour. CMAJ 146:2167\u20132174","journal-title":"CMAJ"},{"key":"9614_CR10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jnci\/87.10.720","volume":"87","author":"WC Black","year":"1995","unstructured":"Black WC, Nease RF Jr., Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50\u00a0years of age. J Natl Cancer Inst 87:720\u2013731","journal-title":"J Natl Cancer Inst"},{"key":"9614_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0039-6060(96)80301-1","volume":"120","author":"BL Smith","year":"1996","unstructured":"Smith BL, Gadd MA, Lawler C et al (1996) Perception of breast cancer risk among women in breast center and primary care settings: correlation with age and family history of breast cancer. Surgery 120:297\u2013303","journal-title":"Surgery"},{"key":"9614_CR12","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archinte.161.13.1639","volume":"161","author":"L Bastian","year":"2001","unstructured":"Bastian L, Lipkus I, Kuchibhatia M et al (2001) Women\u2019s interest in chemoprevention for breast cancer. Arch Intern Med 161:1639\u20131644","journal-title":"Arch Intern Med"},{"key":"9614_CR13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","volume":"91","author":"MH Gail","year":"1999","unstructured":"Gail MH, Costantino JP, Bryant J, et al (1999) Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91:1829\u20131846","journal-title":"J Natl Cancer Inst"},{"key":"9614_CR14","doi-asserted-by":"crossref","unstructured":"Doshi JA, Brandt N, Stuart B (2004) The impact of drug coverage on COX-2 inhibitor use in medicare. Health Aff Jan\u2013Jun; Suppl Web Exclusives:W4-94-105","DOI":"10.1377\/hlthaff.W4.94"},{"key":"9614_CR15","first-page":"366","volume":"103","author":"P Remington","year":"1998","unstructured":"Remington P, Smith M, Williamson D et al (1998) Design, characteristics, and usefulness of state-based behavioral risk factor surveillance: 1981\u201387. Public Health Rep 103:366\u2013375","journal-title":"Public Health Rep"},{"key":"9614_CR16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879\u20131886","journal-title":"J Natl Cancer Inst"},{"key":"9614_CR17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-114-8-657","volume":"114","author":"C Lerman","year":"1991","unstructured":"Lerman C, Trock B, Rimer BK et al (1991) Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 114:657\u2013661","journal-title":"Ann Intern Med"},{"key":"9614_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1037\/0278-6133.10.4.259","volume":"10","author":"C Lerman","year":"1991","unstructured":"Lerman C, Trock B, Rimer BK et al (1991) Psychological side effects of breast cancer screening. Health Psychol 10:259\u2013267","journal-title":"Health Psychol"},{"key":"9614_CR19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371\u20131388","journal-title":"J Natl Cancer Inst"},{"key":"9614_CR20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","volume":"352","author":"T Powles","year":"1998","unstructured":"Powles T, Eeles R, Ashley S et al (1998) Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 352:98\u2013101","journal-title":"Lancet"},{"key":"9614_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)85011-3","volume":"352","author":"U Veronesi","year":"1998","unstructured":"Veronesi U, Maisonneuve P, Costa A et al (1998) Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 352:93\u201397","journal-title":"Lancet"},{"key":"9614_CR22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1525-1497.1998.00115.x","volume":"13","author":"C Kiefe","year":"1998","unstructured":"Kiefe C, Funkhouse E, Fouad M et al (1998) Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 13:357\u2013365","journal-title":"J Gen Intern Med"},{"key":"9614_CR23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/0278-6133.18.5.532","volume":"18","author":"M Diefenbach","year":"1999","unstructured":"Diefenbach M, Miller S, Daly M (1999) Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol 18:532\u2013536","journal-title":"Health Psychol"},{"key":"9614_CR24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1037\/0278-6133.15.6.423","volume":"15","author":"K McCaul","year":"1996","unstructured":"McCaul K, Branstetter A, Schroeder D et al (1996) What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol 15:423\u2013429","journal-title":"Health Psychol"},{"issue":"1 Suppl","key":"9614_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cncr.11018","volume":"97","author":"ML Bondy","year":"2003","unstructured":"Bondy ML, Newman LA (2003) Breast cancer risk assessment models: applicability to African-American women. Cancer 97(1 Suppl):230\u2013235","journal-title":"Cancer"},{"key":"9614_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","volume":"51","author":"RT Greenlee","year":"2001","unstructured":"Greenlee RT, Hill-Harmon MB, Murray T (2001) Cancer Statistics, 2001. CA Cancer J Clin 51:15\u201336","journal-title":"CA Cancer J Clin"},{"key":"9614_CR27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley M, Ries L et al (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55\u00a0years and older. JAMA 285:885\u2013892","journal-title":"JAMA"},{"key":"9614_CR28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1056\/NEJMe068120","volume":"355","author":"ML Stefanick","year":"2006","unstructured":"Stefanick ML (2006) Risk-benefit profiles of raloxifene for women. N Engl J Med 355:190\u2013192","journal-title":"N Engl J Med"},{"key":"9614_CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","volume":"355","author":"E Barrett-Connor","year":"2006","unstructured":"Barrett-Connor E, Mosca L, Collins P et al (2006) Effects of Raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355:125\u2013137","journal-title":"N Engl J Med"},{"key":"9614_CR30","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1001\/jama.295.23.jed60037","volume":"295","author":"WJ Gradishar","year":"2006","unstructured":"Gradishar WJ, Cella D (2006) Selective estrogen receptor modulators and prevention of invasive breast cancer. JAMA 295:2784\u20132786","journal-title":"JAMA"},{"key":"9614_CR31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7326\/0003-4819-137-1-200207020-00014","volume":"137","author":"AG Mulley","year":"2002","unstructured":"Mulley AG, Sepucha K. (2002) Making good decisions about breast cancer chemoprevention. Ann Intern Med 137:52\u201354","journal-title":"Ann Intern Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9614-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-007-9614-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9614-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:50Z","timestamp":1559233730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-007-9614-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["9614"],"URL":"https:\/\/doi.org\/10.1007\/s10549-007-9614-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,7]]}}}